Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01308788 · ClinicalTrials.gov registry record
Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow
A clinical trial of Glaucoma, sponsored by Indiana University.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT01308788: Completed study of Glaucoma, sponsored by Indiana University.
NCT01308788 is a study of Glaucoma that has completed, run by Indiana University. The registered enrollment target is 35 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01308788, a study of Glaucoma, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study will be to compare the aqueous production suppressant to aqueous outflow drugs in terms of the response to known vascular parameters. Specifically; systemic perfusion pressure, retrobulbar blood flow and retinal microcirculation.
Conditions Studied
Study Locations (1)
Indiana
- Department of Ophthalmology Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-10 |
What the finished NCT01308788 record still lists
NCT01308788 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01308788 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT01308788 about?
NCT01308788 is a clinical study titled "Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow". The purpose of this study will be to compare the aqueous production suppressant to aqueous outflow drugs in terms of the response to known vascular parameters. Specifically; systemic perfusion pressure, retrobulbar blood flow and retinal microcirculation.
What is the current status of trial NCT01308788?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2011-03. Estimated completion is 2012-10.
What conditions does trial NCT01308788 study?
This clinical trial studies the following conditions: Glaucoma.
Who is sponsoring clinical trial NCT01308788?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01308788 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01308788's enrollment target sits among peer trials
35 77th of 92 higher than 15 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia